284 related articles for article (PubMed ID: 31584860)
21. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
22. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
23. [CT diagnosis of intraductal papillary mucinous tumor of the pancreas].
Wang DQ; Ji Y; Shi X; Rao SX; Ye T; Jin DY; Lou WH; Zeng MS
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):606-8. PubMed ID: 17236556
[TBL] [Abstract][Full Text] [Related]
24. Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history.
Fernandes SR; Correia LA; Antunes T; Cortez-Pinto H
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27001600
[TBL] [Abstract][Full Text] [Related]
25. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of main pancreatic duct dilation on computed tomography: single and double duct dilation.
Edge MD; Hoteit M; Patel AP; Wang X; Baumgarten DA; Cai Q
World J Gastroenterol; 2007 Mar; 13(11):1701-5. PubMed ID: 17461473
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
28. Cystic form of paraduodenal pancreatitis (cystic dystrophy in heterotopic pancreas (CDHP)): a potential link with minor papilla abnormalities? A study in a large series.
Wagner M; Vullierme MP; Rebours V; Ronot M; Ruszniewski P; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):199-205. PubMed ID: 25991480
[TBL] [Abstract][Full Text] [Related]
29. Are pancreatic calcifications specific for the diagnosis of chronic pancreatitis? A multidetector-row CT analysis.
Campisi A; Brancatelli G; Vullierme MP; Levy P; Ruszniewski P; Vilgrain V
Clin Radiol; 2009 Sep; 64(9):903-11. PubMed ID: 19664481
[TBL] [Abstract][Full Text] [Related]
30. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; de Llorens R; Aleixandre RN; Peracaula R
PLoS One; 2016; 11(1):e0147214. PubMed ID: 26808421
[TBL] [Abstract][Full Text] [Related]
31. Criteria for Determining Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm Based on Computed Tomography.
Mönnings P; Belyaev O; Uhl W; Giese A; Tannapfel A; Köster O; Meier JJ
Digestion; 2016; 94(4):230-239. PubMed ID: 28030856
[TBL] [Abstract][Full Text] [Related]
32. CT and MR features that can help to differentiate between focal chronic pancreatitis and pancreatic cancer.
Srisajjakul S; Prapaisilp P; Bangchokdee S
Radiol Med; 2020 Apr; 125(4):356-364. PubMed ID: 31933064
[TBL] [Abstract][Full Text] [Related]
33. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
35. Imaging mimics of pancreatic ductal adenocarcinoma.
Gandhi NS; Feldman MK; Le O; Morris-Stiff G
Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
[TBL] [Abstract][Full Text] [Related]
36. Invasive carcinoma of the pancreas derived from intraductal papillary adenocarcinoma without mucin hypersecretion but with changes in the pancreatic duct on pancreatography.
Ariizumi S; Hatori T; Imaizumi H; Suzuki T; Akimoto S; Takasaki K
J Hepatobiliary Pancreat Surg; 2002; 9(5):637-41. PubMed ID: 12541053
[TBL] [Abstract][Full Text] [Related]
37. "Biliary Diseases with Pancreatic Counterparts": Cross-sectional Imaging Findings.
Katabathina VS; Flaherty EM; Dasyam AK; Menias CO; Riddle ND; Lath N; Kozaka K; Matsui O; Nakanuma Y; Prasad SR
Radiographics; 2016; 36(2):374-92. PubMed ID: 26824512
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
39. The Role of Endoscopic Retrograde Cholangiopancreatography in Management of Pancreatic Diseases.
Riff BP; Chandrasekhara V
Gastroenterol Clin North Am; 2016 Mar; 45(1):45-65. PubMed ID: 26895680
[TBL] [Abstract][Full Text] [Related]
40. Endolumenal ultrasonography in the diagnosis of pancreatic diseases.
Yamao K; Okubo K; Sawaka A; Hara K; Nakamura T; Suzuki T; Shimizu Y; Ozden I
Abdom Imaging; 2003; 28(4):545-55. PubMed ID: 14580099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
